Screener
BioCryst Pharmaceuticals BCRX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's gross margin?
- BioCryst Pharmaceuticals (BCRX) reported gross margin of 97.8% in Q2 2026.
- How has BioCryst Pharmaceuticals's gross margin changed year-over-year?
- BioCryst Pharmaceuticals's gross margin increased by 0.8% year-over-year, from 97% to 97.8%.
- What is the long-term trend for BioCryst Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's gross margin has grown at a 1.4% compound annual growth rate (CAGR), from 91.3% to 97.8%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about BioCryst Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude